• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong.

作者信息

Ip Tai-Pang, Cheung Shing-Kee William, Cheung Tak-Cheong, Choi Tak-Cheong, Chow Siu-Lun Eddie, Ho Yiu-Yan Andrew, Kan Sik-Yau Anita, Kung Wai-Chee Annie, Lee Ka-Kui, Leung Ka-Li Frankie, Leung Yin-Yan Jenny, Lo Seen-Tsing Sue, Sy Chung-Tai, Wong Yat-Wa

出版信息

Hong Kong Med J. 2013 Apr;19 Suppl 2:1-40.

PMID:23535738
Abstract
摘要

相似文献

1
The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong.香港骨质疏松症学会（OSHK）：2013年香港绝经后骨质疏松症临床管理OSHK指南。
Hong Kong Med J. 2013 Apr;19 Suppl 2:1-40.
2
2024 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong.《2024年香港绝经后骨质疏松症临床管理的职业安全与健康指南》
Hong Kong Med J. 2024 Apr;30 Suppl 2:1-44.
3
Cost-effective osteoporosis intervention thresholds for Hong Kong postmenopausal women.香港绝经后妇女具有成本效益的骨质疏松症干预阈值。
Hong Kong Med J. 2015 Dec;21 Suppl 6:13-6.
4
[New French recommendations for the treatment of post-menopausal osteoporosis. What are the implications for the general internists?].[法国绝经后骨质疏松症治疗的新建议。对普通内科医生有何影响？]
Rev Med Interne. 2014 Jan;35(1):1-3. doi: 10.1016/j.revmed.2013.05.007. Epub 2013 Jun 10.
5
Screening for osteoporosis.骨质疏松症筛查
Am Fam Physician. 2011 May 15;83(10):1201-2.
6
Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures .服用依从性双磷酸盐的时间与骨质疏松性骨折风险的关系。
Curr Med Res Opin. 2008 Nov;24(11):3217-22. doi: 10.1185/03007990802470241. Epub 2008 Oct 14.
7
Pharmacologic management of osteoporosis.骨质疏松症的药物治疗
J Obstet Gynecol Neonatal Nurs. 2014 Mar-Apr;43(2):236-45; quiz E20-1. doi: 10.1111/1552-6909.12285. Epub 2014 Feb 6.
8
Screening for osteoporosis: recommendation statement.骨质疏松症筛查：推荐声明。
Am Fam Physician. 2011 May 15;83(10):1197-200.
9
Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women.
Clin Endocrinol (Oxf). 2014 Feb;80(2):200-7. doi: 10.1111/cen.12322. Epub 2013 Oct 10.
10
[Osteoporosis in women - well known but not treated].
MMW Fortschr Med. 2015 Nov 12;157 Spec No 2:73-7; quiz 78. doi: 10.1007/s15006-015-3301-1.

引用本文的文献

1
Bisphosphonates and the risk of dementia in patients with osteoporosis or fragility fracture: A population-based study in Hong Kong.双膦酸盐与骨质疏松症或脆性骨折患者的痴呆风险：一项基于香港人群的研究。
Alzheimers Dement. 2025 Jul;21(7):e70503. doi: 10.1002/alz.70503.
2
Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis.接受双膦酸盐类药物治疗骨质疏松症所致非典型股骨骨折患者的临床特征、骨密度参数及结局。
Endocrine. 2024 Apr;84(1):223-235. doi: 10.1007/s12020-023-03608-z. Epub 2023 Nov 20.
3
Recommendations on deprescribing of bisphosphonates in osteoporosis guidelines: a systematic review.
骨质疏松症指南中关于双磷酸盐药物停用的建议：系统评价。
Eur Geriatr Med. 2023 Aug;14(4):747-760. doi: 10.1007/s41999-023-00820-y. Epub 2023 Jul 2.
4
A new osteogenic protein isolated from Thunb accelerates bone defect healing through the mTOR signaling axis.从忍冬属植物中分离出的一种新型成骨蛋白通过mTOR信号轴加速骨缺损愈合。
Bioact Mater. 2023 Apr 23;27:429-446. doi: 10.1016/j.bioactmat.2023.04.018. eCollection 2023 Sep.
5
Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: a systematic review.亚太地区发达经济体骨质疏松症的患病率和相关骨折的发生率：系统评价。
Osteoporos Int. 2023 Jun;34(6):1037-1053. doi: 10.1007/s00198-022-06657-8. Epub 2023 Feb 3.
6
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study.地舒单抗预防真实世界中老年女性骨质疏松性骨折的有效性：一项回顾性队列研究。
Osteoporos Int. 2022 May;33(5):1155-1164. doi: 10.1007/s00198-021-06291-w. Epub 2022 Jan 15.
7
What traditional, complementary, and integrative medicine recommendations exist across osteoporosis clinical practice guidelines? A systematic review and quality assessment.骨质疏松症临床实践指南中有哪些传统、补充和整合医学建议？一项系统评价与质量评估。
Integr Med Res. 2022 Jun;11(2):100803. doi: 10.1016/j.imr.2021.100803. Epub 2021 Oct 28.
8
The first reported fracture liaison service (FLS) for vertebral fractures in China: is muscle the missing gap?中国首个报告的椎体骨折骨折联络服务（FLS）：肌肉是缺失的一环吗？
Arch Osteoporos. 2021 Nov 6;16(1):168. doi: 10.1007/s11657-021-01036-y.
9
Prevalence of osteoporosis in elderly women in Hong Kong.香港老年女性骨质疏松症的患病率。
Osteoporos Sarcopenia. 2021 Sep;7(3):92-97. doi: 10.1016/j.afos.2021.09.001. Epub 2021 Sep 9.
10
Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.亚太骨质疏松症联盟（APCO）框架的制定：亚太地区骨质疏松症筛查、诊断和管理的临床护理标准。
Osteoporos Int. 2021 Jul;32(7):1249-1275. doi: 10.1007/s00198-020-05742-0. Epub 2021 Jan 27.